PolyMedix, Inc. (PYMX) - Medical Equipment - Deals and Alliances Profile
Summary
PolyMedix, Inc. (PolyMedix) is a biotechnology company, which makes use of its proprietary computational drug design technology to develop novel antibiotic compounds and heptagonists for infectious diseases and acute cardiovascular disorders. The product protfolio of the company include, PMX-30063, PMX-60056, both in phase II of clinical development. PMX-50003, PMX-70004 are in pre-clinical stage of development, along with PMX-10072, PMX-30024, PMX-10098, PMX-30016 and PMX-20005. With all its products in various phases of development, ranging from multiple phase II clinical trials to preclinical development, the company currently does not market any product. The company is headquartered in Pennsylvania, the US.
PolyMedix, Inc. (PYMX) - Medical Equipment - Deals and Alliances Profile provides you an in-depth data and trend analysis of the company’s mergers and acquisitions (M&A) and financings. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered by the company over a five year period. The report portrays detailed comparative data on the number of deals and their value subdivided by deal types, markets, and regions, besides highlighting the company's major recent financial deals.
Data presented in this report was derived from GlobalData’s proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.
Scope
Financial Deals - Analysis of the company’s financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year - Chart and table displaying information on the number of deals and value reported by the company by year, for a five year period.
Deals by Type - Chart and table depicting information on the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region for North America, Europe, the Middle East and Africa and South and Central America.
Deals by Market - Chart and table showing information on the number of deals and value reported by the company, by market.
Major Recent Deals - Information on the company's major recent financial deals. Each such deal has a brief summary, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Business Description - A brief description of the company’s operations.
Key Employees – A list of the key executives of the company.
Important Locations and Subsidiaries – A list and contact details of key locations and subsidiaries of the company.
Key Competitors – A list of key competitors of the company.
Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements.
- The profile analyzes the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divesture strategy
- Deals are presented from the company’s core business segments’ perspective to help you understand its corporate strategy
Access detailed information about the company’s recent financial deals that enables you to understand the key deals which have shaped the company
- Major recent deals are presented in detail, which provides information on each deal’s brief summary, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and their biographies and key competitors.
Stay up to date on the major developments affecting the company
- Recent developments in the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research.
- Key elements such as break up of deals by categories and information on detailed major deals are incorporated in the profile to assist your academic or business research needs.
Medical Equipment And Supply Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
PolyMedix, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011 4
PolyMedix, Inc., Medical Equipment Deals By Type, 2005 to YTD 2011 5
PolyMedix, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011 6
PolyMedix, Inc., Medical Equipment, Deals By Market, 2005 to YTD 2011 7
PolyMedix, Inc., Medical Equipment, Deals Summary, 2005 to YTD 2011 8
PolyMedix, Inc., Medical Equipment, Deal Details 9
Venture Financing 9
PolyMedix Secures Additional $4 Million In Series B Financing 9
Equity Offering 10
PolyMedix Completes Private Placement Of $4.25 Million 10
PolyMedix Closes $15 Million Registered Equity Financing 12
PolyMedix Raises $21 Million In Equity Financing 14
Acquisition 15
BTHC II Acquisition Acquires PolyMedix In Reverse Acquisition 15
PolyMedix, Inc. - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 09, 2011: PolyMedix Reports Q2 2011 Results 19
May 09, 2011: PolyMedix Reports Q1 2011 Results 19
Mar 07, 2011: PolyMedix Reports 2010 Results 19
Nov 09, 2010: PolyMedix Reports Q3 2010 Results 19
Aug 16, 2010: PolyMedix Reports Q2 2010 Results 20
May 10, 2010: PolyMedix Reports Q1 2010 Results 20
Mar 12, 2010: PolyMedix Reports 2009 Results 20
Corporate Communications 20
Jan 24, 2011: PolyMedix Promotes Bozena Korczak To Senior Vice President, Drug Development And Chief Development Officer 20
Other Significant Developments 21
Nov 22, 2010: PolyMedix To Present Three Abstracts At Upcoming American Society Of Hematology Meeting 21
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
PolyMedix, Inc., Medical Equipment, Key Facts, 2010 1
PolyMedix, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011 1
PolyMedix, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011 1
PolyMedix, Inc., Medical Equipment, Deals By Market, 2005 to YTD 2011 1
PolyMedix, Inc., Medical Equipment, Deals Summary, 2005 to YTD 2011 1
PolyMedix, Inc., Medical Equipment Deals By Type, 2005 to YTD 2011 5
PolyMedix, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011 6
PolyMedix, Inc., Deals By Market, 2005 to YTD 2011 7
PolyMedix, Inc., Medical Equipment, Deals Summary, 2005 to YTD 2011 8
PolyMedix Secures Additional $4 Million In Series B Financing 9
PolyMedix Completes Private Placement Of $4.25 Million 10
PolyMedix Closes $15 Million Registered Equity Financing 12
PolyMedix Raises $21 Million In Equity Financing 14
BTHC II Acquisition Acquires PolyMedix In Reverse Acquisition 15
PolyMedix, Inc., Key Competitors 16
PolyMedix, Inc., Key Employees 17
PolyMedix, Inc., Subsidiaries 18
List of Figures
PolyMedix, Inc., Medical Equipment, Deals by Type, 2005 to YTD 2011 1
PolyMedix, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011 4
PolyMedix, Inc., Medical Equipment, Deals by Type, 2005 to YTD 2011 5
PolyMedix, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011 6
PolyMedix, Inc., Medical Equipment, Deals by Market, 2005 to YTD 2011 7
Companies mentioned
Astellas Pharma Inc.
Forest Laboratories, Inc.
Basilea Pharmaceutica Ltd.
Theravance, Inc.
The Medicines Company
Trius Therapeutics, Inc.
GlaxoSmithKline plc
Sanofi
Merck & Co., Inc.
Inhibitex, Inc.
NovaBay Pharmaceuticals, Inc.
Cubist Pharmaceuticals, Inc.